Taking Aim at HER3 in Lung Cancers Resistant to EGFR Inhibitors

Gain expert perspectives on the evolving role of HER3 in EGFR-mutated advanced NSCLC including the role of HER3-targeted therapies in the setting of EGFR TKI resistance with this educational program featuring a series of short interactive virtual presentations with downloadable slidesets and a multidisciplinary audio podcast.

Share

Program Content

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.